References
- Buyzere MD, Gruson D. Biomarkers in heart failure. Clin Chim Acta 2015;443:1–2.
- Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002;105:1387–93.
- Dokainish H. Combining tissue Doppler echocardiography and B-type natriuretic peptide in the evaluation of left ventricular filling pressures: review of the literature and clinical recommendations. Can J Cardiol 2007;23:983–9.
- Lowbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest 2004;64:667–76.
- Xue Y, Clopton P, Peacock WF, Maisel AS. Serial changes in high-sensitive troponin I predict outcome in patients with decompensated heart failure. Eur J Heart Fail 2011;13:37–42.
- Joseph SM, Cedars AM, Ewald GA, Geltman EM, Mann DL. Acute decompensated heart failure contemporary medical management. Tex Heart Inst J 2009;36:510–20.
- McKie PM, Heublein DM, Scott CG, Gantzer ML, Mehta RA, Rodeheffer RJ. Defining high sensitivity cardiac troponin concentrations in the community. Clin Chem 2013;59:1099–107.
- Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. J Am Coll Cardiol 2006;47:345–53.
- Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NTproBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004;6:365–8.
- Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP investigation of dyspnoea in the emergency department (PRIDE) echocardiographic sub-study. Eur Heart J 2006;27:839–45.
- Setsuta K, Seino Y, Takahashi N, Ogawa T, Sasaki K, Harada A. Clinical significance of elevated levels of cardiac troponin T in patients with chronic heart failure. Am J Cardiol 1999;84:608–11.
- Sato Y, Yamada T, Taniguchi R, Nagai K, Makiyama T, Okada H. Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes. Circulation 2001;103:369–74.
- Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation 2007;116:1242–9.
- Stanton EB, Hansen MS, Sole MJ, Gawad Y, Packer M, Pitt B. Cardiac troponin I, a possible predictor of survival in patients with stable congestive heart failure. Can J Cardiol 2005;21:39–43.
- Peacock WF, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:2117–26.
- Haider KH, Stimson WH. Cardiac troponin-I: a biochemical marker for cardiac cell necrosis. Dis Markers 1993;11:205–15.
- Behnes M, Espeter F, Hoffmann U, Lang S, Brueckmann M, Akin I, Borggrefe M, Bertsch T, Weiss C, Neumaier M, Ahmad-Nejad P. Diagnostic and long-term prognostic value of sensitive troponin I in symptomatic patients suspected of acute heart failure. Clin Lab 2015;61:1737–47.
- Liang F, Wu J, Garami M, Gardner DG. Mechanical strain increases expression of the brain natriuretic peptide gene in rat cardiac myocytes. J Biol Chem 1997;272:28050–6.
- Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002;89:691–5.
- Ishii J, Cui W, Kitagawa F, Kuno T, Nakamura Y, Naruse H. Prognostic value of combination of cardiac troponin T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem 2003;49:2020–6.
- Taniguchi R, Sato Y, Nishio Y, Kimura T, Kita T. Measurements of baseline and follow-up concentrations of cardiac troponin-T and brain natriuretic peptide in patients with heart failure from various etiologies. Heart Vessels 2006;21:344–9.
- Daniels LB, Laughlin GA, Clopton P, Maisel AS, Barrett-Connor E. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from. The Rancho Bernardo study. J Am Coll Cardiol 2008;52:450–9.
- Fonarow GC, Peacock WF, Horwich TB, Phillips CO, Givertz MM, Lopatin M. Usefulness of B-type natriuretic peptide and cardiac troponin levels to predict in-hospital mortality from ADHERE. Am J Cardiol 2008;101:231–7.
- Ilva T, Lassus J, Siirila-Waris K, Melin J, Peuhkurinen K, Pulkki K. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008;10:772–9.
- McKie PM, AbouEzzeddine OF, Scott CG, Mehta R, Rodeheffer RJ, Redfield MM. High-sensitivity troponin I and amino-terminal pro-B-type natriuretic peptide predict heart failure and mortality in the general population. Clin Chem 2014;60:1225–33.